Prevention of shockwave induced functional and morphological alterations: An overwiew

Archivio Italiano di Urologia e Andrologia

Volumn 80, Issue 1, 2008, Pages 27-33

  Sarica, Kemal ^a   Yencilek, Faruk ^a  

^a YEDITEPE UNIVERSITY   (Turkey)

Author keywords

Antioxidant agents; Calcium channel blocking agents; Renal damage; Shock wave lithotripsy

Indexed keywords

ALLOPURINOL; ALPHA TOCOPHEROL; AMLODIPINE; ANTIOXIDANT; CALCIUM CHANNEL BLOCKING AGENT; CITRATE POTASSIUM; GLYCOSAMINOGLYCAN; NIFEDIPINE; OXYGEN RADICAL; SELENIUM; VERAPAMIL;

CRYSTALLIZATION; EXTRACORPOREAL LITHOTRIPSY; HISTOPATHOLOGY; HUMAN; KIDNEY INJURY; NONHUMAN; PHYSICIAN; RENAL PROTECTION; REPERFUSION INJURY; REVIEW;

ANTIOXIDANTS; CALCIUM CHANNEL BLOCKERS; DIURETICS; DRUG THERAPY, COMBINATION; HIGH-ENERGY SHOCK WAVES; HUMANS; KIDNEY CALCULI; KIDNEY DISEASES; LITHOTRIPSY; POTASSIUM CITRATE; RISK FACTORS; TREATMENT OUTCOME;

EID: 42249104373     PISSN: 11243562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. Chaussy C, Eisenberger F, Forssmann B. Extracorporeal Shockwave Lithotripsy (ESWL) (R): a chronology. J Endourol 2007; 21:1249-54.
2. Al-Awadi KA, Kehinde EO, Loutfi I, Mojiminiyi OA, Al-Hunayan A, Abdul-Halim H, Al-Sarraf A, Memon A, Abraham MP. Treatment of renal calculi by lithotripsy: minimizing short-term shock wave induced renal damage by using antioxidants. Urol Res 2008; 36:51-60.
3. Willis LR, Evan AP, Connors BA, Shao Y, Blomgren PM, Pratt JH, Fineberg NS, Lingeman JE. Shockwave lithotripsy: dose-related effects on renal structure, hemodynamics, and tubular function. J.Endourol 2005; 19:90-101.
4. Jaeger P, Redha F, Marquardt K, Uhlschmid G, Hauri D. Morphological and functional changes in canine kidneys following extracorporeal shock wave treatment. Urol Int 2005; 54:48-58.
5. Kishimoto T, Senju M, Sugimoto T, Yamamoto K, Sakamoto W, Iimori M, Kanasawa T, Wada S, Maekawa M. Effects of high energy shock wave exposure on renal function during extracorporeal shock wave lithotripsy for kidney stones. Eur Urol 1990; 18:290.
6. Karalezli, G, Gögüci, O, Bedük, Y, Köküuslu, C, Sarica K, Köksal O. Histopathologic effects of ESWL on rabbit kidney. Urol Res 1993; 21:67-70.
7. Back W, Köhrmann KU, Bensemann J, Rassweiler J, Alken P. Histomorphologic and ultrastructural findings of shockwave-induced lesions in the isolated perfused kidney of the pig. J. Endourol 1994; 8:257-61.
8. Karlsen SJ, Smevik B, Hovig T. Acute morphological changes in canine kidneys after exposure to extracorporeal shock waves: a light and electron microscopic study. Urol Res 1991; 19:105-115.
9. Ferreria U, Claro JA, Netto NR, et al. Functional and histologic alterations in growing solitary rat kidney as a result of extracorporeal shockwaves. J Endourol 1995; 9:45-49.
10. Lipski B, Miller J, Rigaud G, Stack G, Marsh C. Acute renal failure from a subcapsular hematoma in a solitary kidney: an usual complication of extracorporeal shock wave lithotripsy. J Urol 1997; 157:224-225.
11. Villanyi KK, Szekely JG, Farkas LM, Javor E, Pusztai C. Short-term changes in renal function after extracorporeal shock wave lithotripsy in children. J Urol 1991; 166:222-224.
12. Brown SA, Munver R, Delvecchio FC, Kuo RL, Zhong P, Preminger GM. Microdialysis assessment of shock wave lithotripsy-induced renal injury. Urology 2000; 56:364-8.
13. Williams JC Jr, Stonehill MA, Colmenares K, Evan AP, Andreoli SP, Cleveland RO, Bailey MR, Crum LA, McAteer JA.;Effect of macroscopic air bubbles on cell lysis by shock wave lithotripsy in vitro. Ultrasound Med Biol 1999; 25:473-479.
14. Villanyi KK, Szekely JG, Farkas LM, Javor E, Pusztai C. Short-term changes in renal function after extracorporeal shock wave lithotripsy in children. J Urol 2001; 166:222-224.
15. Willis LR, Evan AP, Connors BA, Handa RK, Blomgren PM, Lingeman JE. Prevention of lithotripsy-induced renal injury by pretreating kidneys with low-energy shock waves. J Am Soc Nephrol 2006; 17:663-73.
16. Evan AP, Wills LR, McAteer JA, Bailey MR, Connors BA, Shao Y, Lingeman JE, Williams JC Jr, Finberg NS, Crum LA. Kidney damage and renal functional changes are minimized by waveform control that suppresses cavitation in shockwave lithotripsy. J Urol 2002; 168:1556-1562.
17. Sarica K, Kosar A, Yaman, Beduk Y, Durak I, Gogus s O, Kavukcu M.; Evaluation of ischemia after ESWL: detection of free oxygen radical scavenger enzymes in renal parenchyma subjected to high energy shock waves. Urol Int 1996; 57:221.
18. Sarica K., Erbagci A., Yagci F, Bakir K, Erturhan S, Ucak R. Limitation of apoptotic changes in renal tubular cell injury induced by hyperoxaluria. Urol Res 2004; 32:271-277.
19. Morgan TR, Laudone VP, Heston WD, Zeitz L, Fair WR. Free radical production by high energy shock waves-comparison with ionizing irradiation. J Urol 1988; 139:186.
20. Munver R, Delvecchio FC, Kuo RL, Brown SA, Zhong P, Preminger GM. In vivo assessment of free radical activity during shock wave lithotripsy using a microdialysis system:The renoprotective action of allopurinol. J Urol 2002; 167:327-34.
21. Suhr D, Brummer F, Hulser DF. Cavitation-generated free radicals during shock wave exposure: investigations with cell-free solutions and suspended cells. Ultrasound Med Biol 1991; 17:761.
22. Wang JH, Chen HS, Wang T, Diao YF, Tian KL. Oxygen-derived free radicals induced cellular injury in superior mesenteric artery occlusion shock: protective effect of superoxide dismutase. Circ Shock 1990; 32:31-41.
23. Baker GL, Corry RJ, Autor AP. Oxygen free radical induced damage in kidneys subjected to warm ischemia and reperfusion. Protective effect of superoxide dismutase. Ann Surg 1985; 202:628.
24. Delvecchio F, Auge BK, Munver R, Brown SA, Brizuela R, Zhong P, Preminger GM. Shock wave lithotripsy causes ipsilateral renal injury remote from the focal point: the role of regional vasoconstriction. J Urol 2003; 169:1526.
25. Strohmaier WL, Koch J, Balk N, Wilbert DM, Bichler KH. Limitation of shockwave-induced renal tubular dysfunction by nifedipine. Eur Urol 1994; 25:99-104.
26. Loutzenhiser RD, Epstein M. Renal effects of calcium antagonists. J Cardiovascpharmacol 1998; 12:48-52.
27. Schirer RW, Arnold PE, Putter VJ, Burke TJ. Cellular calcium in ischemic acute renal failure: Role of calcium entry blockers. Kidney Int 1987; 32:313-21.
28. Frishman WH. Current status of calcium channel blockers. Curr Probl Cardiol 1994; 19:637-88.
29. Epstein M. Calcium antagonists and renal protection: current status and future perspectives. Arch Intern Med 1002; 152:1573-84.
30. Grossman E, Messerli FH. Cardiac effects of calcium antagonists in hypertension. In: Epstein M, Loutzenhiser R (eds) Calcium antagonists in clinical medicine, Hanley and Belfus, Philadelphia 2002; p. 207-28.
31. Epstein M. Calcium antagonists and the kidney: implications for renal protection. In: Epstein M, Loutzenhiser R (eds) Calcium antagonists in clinical medicine, Hanley and Belfus, Philadelphia 2002; p. 629-64.
32. Epstein M, Loutzenhiser R. Potential applicability of calcium antagonists as renal protective agents. In: Epstein M, Loutzenhiser R (eds) Calcium antagonists and the kidney. Hanley & Belfus, Philadelphia 2002; p. 275-98.
33. Strohmaier WL, Abelius A, Billes I, Grossmann T, Wilbert DM, Bichler KH. Verapamil limits shockwave-induced renal tubular damage in vivo. J Endourol 1994; 8:269-73.
34. Strohmaier WL, Witte B, Nelde HJ. Influence of nifedipine on stone formation and renaL function in cholesterol-induced nephrolithiasis in rats. Urol Int 1994; 52(2):87.
35. Li B, Zhou W, Li P. Protective effects of nifedipine and allopurinol on high energy shock wave induced acute changes of renal function. J Urol1995; 153:596.
36. Strohmaier WL, Bichler KH, Koch J, Balk N, Wilbert DM. Protective effect of verapamil on shock wave induced renal tubular dysfunction. J Urol 1993; 150:27-29.
37. Yaman Ö, Sarica K, Özer G, Soygür T, Kutsal O, Yaman LS, Gö€üfl, O. Protective effect of Verepamil on renal histology following shock wave application in rabbit model. J.Endourol 1996; 10:329-333.
38. Akbay,C., Say>n,C., Sar>ca,K., Soygür,T., Sabuncuo€lu,B.: Effect of verapamil on rabbit renal tissue after shock wave lithotripsy: An ultrastructural approach. Electron Microscopy 1998; 4:493-494.
39. Sar>ca,K., Soygür,T., Yaman,Ö., Özer,G., Say>n,N., Akbay,C., Küpeli,S., Yaman,L.S.: Stone recurrence after shock wave lithotripsy: Evaluation of possible Enhanced crystal deposition in traumatized tissue in rabbit model J. Endourol 1996; 10:513-517.
40. Epstein M. Calcium antagonists in the management of hypertension. In: Epstein M, Loutzenhiser R (eds) Calcium antagonists and the kidney. Hanley & Belfus, Philadelphia:2002; p. 293-313
41. Mason RP, Marche P, Hintze TH. Novel vascular biology of third-generation L-type calcium channel antagonists: ancillary actions of amlodipine. Arterioscler Thromb Vasc Biol 2003; 23:2155-63.
42. Sarica K, Ozer G., Soygur T, Yaman O, Ozer E, Ustun H, Yaman LS, Gogus O. Preservation of shockwave-induced renal histologic changes by dermatan sulphate. Urology 1997; 45:145-150.
43. Köhrmann KU, Rassweiler J, Alken P. The recurrence rates of stones after extracorporeal shockwave lithotripsy. J Urol 1993; 148: 26-30.
44. Carr LK, D'a RJ, Jewet MAS, Ibanez D, Ryan M, Bombardier C. New stone formation: a comparison of extracorporeal shock wave lithotripsy and percutaneous nephrolithotomy. J Urol 1996; 155:1565-1567.
45. Kamihira O, Ono Y, Katoh N, Yamada S, Mizutani K, Ohshima S. Long-term stone recurrence rate after extracorporeal shock wave lithotripsy. J Urol 1996; 156:1267-1271.
46. Fegan JE, Husmann D, Alexander BS, Feagins B, Preminger G. Preservation of renal architecture after extracorporeal shockwave lithotripsy . J Endourol 1991; 5:273-76.
47. Morgan TR, Laudone VP, Heston WD, Zeitz L, Fair WR. Free radical production by high energy shock waves-comparison with ionizing irradiation. J Urol 1988; 139:186.
48. Suhr D, Brummer F, Hulser DF. Cavitation-generated free radicals during shock wave exposure: investigations with cell-free solutions and suspended cells. Ultrasound Med Biol 1991; 17:761.
49. Thamilselvan S, Khan SR, Menon. Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res 2003; 31:3.
50. Thamilselvan S, Khan SR; Oxalate and calcium oxalate crystals are injurious to renal epithelial cells: results of in vivo and in vitro studies. J Nephrol 1998; 11(Suppl 1):66.
51. Scheid C, Koul H, Hill WA, Luber-Narod J, Jonassen J, Honeyman T, Kennington L, Kohli R, Hodapp J, Ayvazian P, Menon M. Oxalate toxicity in LLC-PK1 cells, a line of renal epithelial cells. J Urol 1996; 155:1112.
52. Scheid CR, Koul HK, Kennington L, Hill WA, Luber-Narod J, Jonassen J, Honeyman T, Menon M. Oxalate-induced damage to renal tubular cells. Scanning Microsc 9; 1097-1995.
53. Scheid C, Koul H, Hill WA, Luber-Narod J, Kennington L, Honeyman T, Jonassen J, Menon M. Oxalate toxicity in LLC-PK1 cells: role of free radicals. Kidney Int 1996; 49:413.
54. Cicerello E, Merlo F, Gambaro G, Maccatrozzo L, Fandella A, Baggio B, Anselmo G. Effect of alkaline citrate therapy on clearance of residual renal stone fragments after extracorporeal shock wave lithotripsy in sterile calcium and infection nephrolithiasis patients. J Urol 1994; 151:5-9.
55. Delvecchio FC, Brizuela MR, Khan SR, Byer K, Li Z, Zhong P Preminger GM. Citrate and vitamin E blunt the shock wave-induced free radical surge in an in vitro cell culture model. Urol Res 2003; 33:448-452.
56. Tungsanga K, Sriboonlue P, Futrakul P, Yachantha C, Tosukhowong P. Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment. Urol Res 2005; 33:65-69.
57. Huang HS, Chen CF, Chien CT, Chen J. Possible biphasic changes of free radicals in ethylene glycol-induced nephrolithiasis in rats. BJU Int 2000; 85:1143-1149.
58. Preminger GM, Sakhaee K, Skurla C, Pak CYC. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis. J Urol 1985; 134:20-23.
59. Tapaneya Olarn W. The optimal dose of potassium citrate in the treatment of children with distal renal tubular acidosis. J Med Assoc Thai 2002; 85(Suppl.4):1143-49.
60. Soygür T, Akbay A, Küpeli S. Effect of potassium citrate therapy on stone recurrence and residual fragments after shock wave lithotripsy in lower caliceal urolithiasis: a randomized controlled trial. J Endourol 2002; 16:149-52.
61. Pak CY :Medical management of urinary stone disease. Nephron Clin Pract 2004; 98:49-53.
62. Tekin A. Oral potassium citrate treatment for idiopathic hypocitraturia in children with calcium urolithiasis. J Urol 2002; 168:2572-74.
63. Sarica K, Erturhan S, Yurtseven C, Yagci F. Effect of potassium citrate therapy on stone recurrence and regrowth after extracorporeal shockwave lithotripsy in children. J Endourol 2006; 20:875-879.
64. Li B, Zhou W, Li P. Protective effects of nifedipine and allopurinol on high energy shock wave induced acute changes of renal function. J Urol 1995; 153:596.
65. Jan CR, Chen WC, Lee. YH, Huang JK, Ou HC, Tseng CJ. Allopurinol blocks shock-wave-induced rises in cytosolic calcium levels in MDCK cells. Urol Res 1997; 25:427-432.
66. Biri H, Ozturk HS, Buyukkocak S, Kacmaz M. Antioxidant defense potential of rabbit renal tissues after ESWL: protective effect of antioxidant vitamins application in rabbit model. J Endourol 1998; 13:343-345.
67. Selvam R, Adhirai M. Vitamin E pretreatment prevents Cyclosporin A induced crystal deposition in hyperoxaluric rats. Nephron 1997; 75:77-81.
68. Wu SH, Oldfield JE, Whanger PD, Weswig PH. Effect of selenium, vitamin E and antioxidants on testicular function in rats. Biol Reprod 1973; 8:625.
69. McCay PB. Vitamin E: interactions with free radicals and ascorbate. Annu Rev Nutr 1985; 5:323.
70. Niki E. Antioxidants in relation to lipid peroxidation. Chem Phys Lipids 1987; 44:227.
71. Packer JE, Slater TF, Willson RL. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 1979; 278:737.
72. Packer L, Maguire JJ, Mehlhorn RJ, Serbinova E, Kagan VE. Mitochondria and microsomal membranes have a free radical reductase activity that prevents chromanoxyl radical accumulation. Biochem Biophys Res Commun 1989; 159:229.
73. Khan SR. Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol Res 2005; 33:349-357.
74. Yu RA, Xia T, Wang AG, Chen XM. Effects of selenium and zinc on renal oxidative stress and apoptosis induced by fluoride in rats. Biomed Environ Sci 2006; 19:439-44.
75. Naziroglu M, Karaoglu A, Aksoy AO. Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology 2004; 195:221-30.
76. Strohmaier WL, Billes IC, Abelius A, Lahme S, Bichler KH. Selenium reduces high energy shock wave-induced renal injury in rats. Urol Res 2002, 30:31-4.
77. Strohmaier WL, Lahme S, Weidenbach PM, Bichler KH. Reduction of high-energy shock-wave-induced renal tubular injury by selenium. Urol Res 1999; 27:382-5.
78. Li X, He D, Zhang L, Cheng X, Sheng B, Luo Y. A novel antioxidant agent, astragalosides, prevents shock wave-induced renal oxidative injury in rabbits. Urol Res 2006; 34:277-82.
79. Jeong BC, Kim BS, Kim JI, Kim HH. Effects of green tea on urinary stone formation: an in vivo and in vitro study. J Endourol 2006, 20:356-61.
80. Choi JH, Choi YM, Joo GJ, Rhee IK, Lee IS, Kim KR, Choi MS, Rhee SJ. Effects of green tea catechin on polymorphonuclear leukocyte 5′-lipoxygenase activity, leukotriene B4 synthesis, and renal damage in diabetic rats. Ann Nutr Metab 2004; 48:151-5.
81. Sachse A, Wolf G. Angiotensin II-induced reactive oxygen species and the kidney. J Am Soc Nephrol 2007; 18:2439-46.
82. Takahashi T, Konta T, Takasaki S, Ichikawa K, Takeishi Y, Kubota I. An angiotensin II type-I receptor blocker, olmesartan medoxomil, attenuates lipid peroxidation in renal injury induced by subtotal nephrectomy. Clin Exp Nephrol 2007; 11:202-8.
83. Unal D, Yeni E, Erel O, Bitiren E, Vural H. Antioxidative effects of exogenous nitric oxide versus antioxidant vitamins on renal ischemia reperfusion injury. Urol Res 2002; 30:190-194.